Projects
Multi-dimensional investigation of mobility related fatigability in persons with multiple sclerosis, and effects of cognitive-motor interventions. Hasselt University
Neurophysiology of cognition in multiple sclerosis. Vrije Universiteit Brussel
Finding a highly accurate biomarker for CDiMS would be game changing for patients adjusting their life-plans, neurologists advising their patients on optimal treatment strategies, and researchers developing new ...
Investigating Demyelination in Multiple Sclerosis Using a Multi-Disciplinary Approach. KU Leuven
Magnetisation transfer ratio (MTR) as a surrogate marker for disease heterogeneity in multiple sclerosis (MS). KU Leuven
Multiple sclerosis (MS) is a common neurological disease mostly affecting young adults and leading to significant physical and cognitive disability. From the clinical point of view it is a very heterogeneous disease, which means that the clinical evolution differs from patient to patient, and within one patient even from time to time. It is an autoimmune disease in which genetic as well as environmental factors affect susceptibility and ...
Multiple sclerosis postdoctoral research fellowship Emanuela Oldoni. KU Leuven
“ECTRIMS postdoctoral research fellowship exchange program” is a European program for young researchers in neuroscience. It facilitates the training in research related to multiple sclerosis (MS) and the main goal is to maximize exchange of information and to help grow well-trained research scientists focused on problems in MS.
MS is the most common neurological disorder of young adults and its cause is still unknown. It is ...
Interaction of regulatory T cells with cells of the central nervous system in multiple sclerosis Hasselt University
Heterogeneity in multiple sclerosis. Insights from imaging, immunology and genetics KU Leuven
Background: Multiple sclerosis is an autoimmune disease in which disease heterogeneity is poorly understood. Improving our understanding of pathways that determine inter-patient variation generates new insights that can advance the therapeutic landscape with tailored treatment options.
Objective: By focusing on imaging, immunology and genetics, we aim to unravel how patients differ from one another and how mechanistically different ...
Somatic mutations explain missing risk of multiple sclerosis. KU Leuven
Somatic mutations explain missing risk in multiple sclerosis
An Goris, Laboratory for Neuroimmunology, KU Leuven
1. State of the art
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, affecting 2.5 million
people worldwide and leading to important physical and cognitive disability with typical onset during
young adulthood. A genetic component has long been demonstrated and through ...